The gene of SAR11 HIMB114 TAT rhodopsin, whose codon was optimized for an Escherichia coli expression system, was synthesized (Eurofins Genomics Inc.) and subcloned into a pET21a (+)-vector with a C-terminal 6×His-tag [21 (link),22 (link)]. For mutagenesis, a Quick-change site-directed mutagenesis kit (Stratagene) was used based on a standard protocol [23 (link),24 (link)]. WT and T82D mutant protein were expressed in the E. coli C43 (DE3) strain. The plasmid was prepared using the Nucleo Spin Plasmid Easy pure kit and 3 mL bacterial culture initiated from single colonies selected from a transformation plate. Protein expression was induced by 1.0 mM isopropyl β-D-thiogalactopyranoside (IPTG) for 4 h at 37°C in the presence of 10 μM all-trans-retinal (Sigma-Aldrich). The expressed proteins were purified from E. coli cells according to previously reported methods [23 (link),24 (link)]. The cells were disrupted with a French Press (Ohtake) and the membrane fraction was collected by ultracentrifugation at 125,000 g for 1 h. The protein was solubilized in 2.0% n-dodecyl-β-D-maltoside (DDM) in the presence of 300 mM NaCl, 5 mM imidazole and 50 mM MES (pH 6.5). After Co2+-NTA affinity chromatography, the collected fractions were dialyzed against a buffer containing 50 mM Tris–HCl pH 8.0, 150 mM NaCl and 0.03 % DDM to remove imidazole.